Siddi, M.; Molinari, P.; Alfieri, C.M.; Tangredi, M.; Lunghi, G.; Colombo, E.; Uceda Renteria, S.; Grimaldi, E.; Ceriotti, F.; Castellano, G.;
et al. Prevalence and Risk Factors for Anti-SARS-CoV-2 Antibody in Chronic Kidney Disease (Dialysis Independent and Not). Pathogens 2022, 11, 572.
https://doi.org/10.3390/pathogens11050572
AMA Style
Siddi M, Molinari P, Alfieri CM, Tangredi M, Lunghi G, Colombo E, Uceda Renteria S, Grimaldi E, Ceriotti F, Castellano G,
et al. Prevalence and Risk Factors for Anti-SARS-CoV-2 Antibody in Chronic Kidney Disease (Dialysis Independent and Not). Pathogens. 2022; 11(5):572.
https://doi.org/10.3390/pathogens11050572
Chicago/Turabian Style
Siddi, Mariana, Paolo Molinari, Carlo Maria Alfieri, Marianna Tangredi, Giovanna Lunghi, Elisa Colombo, Sara Uceda Renteria, Emanuele Grimaldi, Ferruccio Ceriotti, Giuseppe Castellano,
and et al. 2022. "Prevalence and Risk Factors for Anti-SARS-CoV-2 Antibody in Chronic Kidney Disease (Dialysis Independent and Not)" Pathogens 11, no. 5: 572.
https://doi.org/10.3390/pathogens11050572
APA Style
Siddi, M., Molinari, P., Alfieri, C. M., Tangredi, M., Lunghi, G., Colombo, E., Uceda Renteria, S., Grimaldi, E., Ceriotti, F., Castellano, G., & Fabrizi, F.
(2022). Prevalence and Risk Factors for Anti-SARS-CoV-2 Antibody in Chronic Kidney Disease (Dialysis Independent and Not). Pathogens, 11(5), 572.
https://doi.org/10.3390/pathogens11050572